Agios Pharmaceuticals' (NASDAQ:AGIO) Chief Scientific Officer Bruce Car is stepping down at the end of July and the company is planning to reduce up to 50 jobs focused on exploratory research as the biotech rejigs itself again after the oncology divestiture.
https://seekingalpha.com/news/3839879-agios-chief-scientific-officer-to-depart-amid-layoffs-as-company-pivots-to-genetic-diseases